Houseviews: 4 stocks to trade during Budget week

Houseviews: 4 stocks to trade during Budget week
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead Travelcafe
moneycontrol.com
Houseviews: 4 stocks to trade during Budget week
  • 
	IDFC

	Brokerage: Morgan Stanley

	Rating: Equalweight

	Target: Rs 150

	Rationale: RBI’s regulations on new bank licenses are unclear for NBFCs, which do not have a promoter group. Since, IDFC has no promoter, it is not clear who can form the required financial holding company, and whether it is eligible.
	 

    IDFC Brokerage: Morgan Stanley Rating: Equalweight Target: Rs 150 Rationale: RBI’s regulations on new bank licenses are unclear for NBFCs, which do not have a promoter group. Since, IDFC has no promoter, it is not clear who can form the required financial holding company, and whether it is eligible.  

  • 
	Britannia

	Brokerage: Standard Chartered

	Rating: Outperform

	Target: Rs 590

	Rationale: Visibility on margin expansion has improved due to recent price hikes and an improving mix.

    Britannia Brokerage: Standard Chartered Rating: Outperform Target: Rs 590 Rationale: Visibility on margin expansion has improved due to recent price hikes and an improving mix.

  • 
	Ranbaxy

	Brokerage: HSBC

	Rating: Overweight

	Target: Rs 482

	Rationale: Ranbaxy's re-entry in the generic lipitor market and the approval to resume manufacturing at Ohm's labs in the US are key positive catalysts.

    Ranbaxy Brokerage: HSBC Rating: Overweight Target: Rs 482 Rationale: Ranbaxy's re-entry in the generic lipitor market and the approval to resume manufacturing at Ohm's labs in the US are key positive catalysts.

  • 
	L&T Finance

	Brokerage: JP Morgan

	Rating: Neutral

	Target: Rs 80

	Rationale: While the stock is fully valued at the current share price, near term catalysts like a new banking license and possible rate cuts provide strong support.

    L&T Finance Brokerage: JP Morgan Rating: Neutral Target: Rs 80 Rationale: While the stock is fully valued at the current share price, near term catalysts like a new banking license and possible rate cuts provide strong support.

  • 
	IDFC

	Brokerage: Morgan Stanley

	Rating: Equalweight

	Target: Rs 150

	Rationale: RBI’s regulations on new bank licenses are unclear for NBFCs, which do not have a promoter group. Since, IDFC has no promoter, it is not clear who can form the required financial holding company, and whether it is eligible.
	 
  • 
	Britannia

	Brokerage: Standard Chartered

	Rating: Outperform

	Target: Rs 590

	Rationale: Visibility on margin expansion has improved due to recent price hikes and an improving mix.
  • 
	Ranbaxy

	Brokerage: HSBC

	Rating: Overweight

	Target: Rs 482

	Rationale: Ranbaxy's re-entry in the generic lipitor market and the approval to resume manufacturing at Ohm's labs in the US are key positive catalysts.
  • 
	L&T Finance

	Brokerage: JP Morgan

	Rating: Neutral

	Target: Rs 80

	Rationale: While the stock is fully valued at the current share price, near term catalysts like a new banking license and possible rate cuts provide strong support.

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login